Trial intelligence / Profile preview

Ulinastatin for Systemic Inflammatory Response in Cardiac Surgery

NCT01518569Phase 4Completed

Sponsor
Konkuk University Medical Center
Start
Mar 2008
Primary completion
Jun 2008
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 4 trial of ulinastatin in Systemic Inflammatory Response Syndrome (SIRS), sponsored by Konkuk University Medical Center. Started Mar 2008; status: completed.

02

Drugs

ulinastatin
03

Conditions

Systemic Inflammatory Response Syndrome (SIRS)

Beyond the preview

Go deeper on NCT01518569.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01518569.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call